Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-01

Clinical Trial Update: Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of azelaic acid 15% foam for papulopustular rosacea. Results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic Acid Foam 15% (azelaic acid)

Snippet

Sponsor: LEO Pharma | Conditions: Papulopustular Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2013-07-01